Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicholas Roller"'
Autor:
Jeffrey Schlom, Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enríquez, Caroline Jochems Frohlich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9cd05848193448979ffe5753410e7cff
Autor:
Samuel T. Pellom, Claire Smalley Rumfield, Y. Maurice Morillon II, Nicholas Roller, Lisa K. Poppe, Douglas E. Brough, Helen Sabzevari, Jeffrey Schlom, Caroline Jochems
Publikováno v:
JCI Insight, Vol 6, Iss 7 (2021)
There are approximately 44,000 cases of human papillomavirus–associated (HPV-associated) cancer each year in the United States, most commonly caused by HPV types 16 and 18. Prophylactic vaccines successfully prevent healthy people from acquiring HP
Externí odkaz:
https://doaj.org/article/23d2fa7a4ec74f2a9d94ecf908385524
Autor:
Helen Sabzevari, Jeffrey Schlom, Nicholas Roller, Samuel T. Pellom, Claire Smalley Rumfield, Douglas E. Brough, Caroline Jochems, Lisa K. Poppe, Y. Maurice Morillon
Publikováno v:
JCI Insight
JCI Insight, Vol 6, Iss 7 (2021)
JCI Insight, Vol 6, Iss 7 (2021)
There are approximately 44,000 cases of human papillomavirus–associated (HPV-associated) cancer each year in the United States, most commonly caused by HPV types 16 and 18. Prophylactic vaccines successfully prevent healthy people from acquiring HP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112338e58ea596f70b12e172e6c75e0d
https://doi.org/10.1172/jci.insight.141912
https://doi.org/10.1172/jci.insight.141912
Autor:
Ariana Sabzevari, Claire Smalley Rumfield, Nicholas Roller, Claudia Palena, John W. Greiner, Y. Maurice Morillon, Caroline Jochems, Samuel T Pellom, Jeffrey Schlom, Lucas A. Horn
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
The lack of serial biopsies in patients with a range of carcinomas has been one obstacle in our understanding of the mechanism of action of immuno-oncology agents as well as the elucidation of mechanisms of resistance to these novel therapeutics. Whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beea5e6cf4faa25c5ac7e7ca02103621
https://doi.org/10.3389/fonc.2020.00549
https://doi.org/10.3389/fonc.2020.00549
Autor:
Samuel Troy Pellom, Claire Smalley Rumfield, Yves Maurice Morillon, Nicholas Roller, Douglas Brough, Helen Sabzevari, Jack Greiner, Jeffrey Schlom, Caroline Jochems
Publikováno v:
The Journal of Immunology. 204:91.6-91.6
There are about 44,000 cases of Human Papilloma Virus (HPV) associated cancer each year in the US, most commonly caused by HPV 16 and 18. Prophylactic vaccines have been successful at preventing healthy patients from acquiring HPV infections via the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd67fa954bf8127d735e241b01689599
https://doi.org/10.4049/jimmunol.204.supp.91.6
https://doi.org/10.4049/jimmunol.204.supp.91.6